Sensei Biotherapeutics (NASDAQ: SNSE), a Future Ventures portfolio company focused on advancing a new and disruptive class of immunotherapies for cancer and infectious diseases, closes its IPO.
For more information on Sensei Biotherapeutics, visit www.senseibio.com.
Global Space Ventures 